鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02251 鹰瞳科技-B

未开盘 05-06 15:59:24

11.300

-0.110

-0.96%

最高11.410	最低11.300	成交量4.47万
今开11.410	昨收11.410	日振幅0.96%
总市值11.53亿	流通市值11.53亿	总股本1.02亿
成交额50.80万	换手率0.04%	流通股本1.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02251","market":"HK","secType":"STK","nameCN":"鹰瞳科技-B","latestPrice":11.3,"timestamp":1778054364679,"preClose":11.41,"halted":0,"volume":44700,"delay":0,"changeRate":-0.009640666082383825,"floatShares":102000000,"shares":102000000,"eps":-0.2809136395142018,"marketStatus":"未开盘","change":-0.11,"latestTime":"05-06 15:59:24","open":11.41,"high":11.41,"low":11.3,"amount":508043,"amplitude":0.009641,"askPrice":11.4,"askSize":200,"bidPrice":11.3,"bidSize":6100,"shortable":0,"etf":0,"ttmEps":-0.2809136395142018,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778117400000},"marketStatusCode":0,"adr":0,"listingDate":1636041600000,"exchange":"SEHK","adjPreClose":11.41,"openAndCloseTimeList":[[1778031000000,1778040000000],[1778043600000,1778054400000]],"volumeRatio":2.375133,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02251","defaultTab":"news","newsList":[{"id":"1101643737","title":"鹰瞳科技-B更新2026年4月股份变动月报表，股本维持103,568,013股","url":"https://stock-news.laohu8.com/highlight/detail?id=1101643737","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101643737?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:01","pubTimestamp":1778061673,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司于2026年5月6日发布截至2026年4月30日的股份变动月报表。公告显示，截至本月底，公司注册股本为103,568,013股，与上月底持平，未发生注册股本规模变化。根据月报披露，本月底已发行股份数为102,265,413股，库存股数为1,302,600股；与上月底相比，已发行股份减少215,800股，库存股增加215,800股，总股本仍维持在103,568,013股。该公告由董事张大磊签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632982546","title":"港股异动 | 德适-B(02526)涨超15%创上市新高 德适携自研iMedImage®医学影像基座大模型亮相广交会","url":"https://stock-news.laohu8.com/highlight/detail?id=2632982546","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632982546?lang=zh_cn&edition=full","pubTime":"2026-05-04 10:27","pubTimestamp":1777861643,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，德适-B早盘涨超15%，高见335港元创上市新高，较招股价99港元已涨近240%。德适携自主研发的iMedImage医学影像基座大模型亮相，展台前人流如织，来自中东、东南亚、欧洲等地的采购商对其技术和产品表现出浓厚兴趣。技术许可收入暴增332%，验证了大模型商业闭环的可行性；30.6%的市占率，守住了政策性刚需赛道的绝对领先地位；而iMedImage基座模型获得腾讯等头部机构的背书，则深刻印证了其作为全球AI医疗基础设施服务商的战略价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437759.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","VXUS","02526","IPOS","BK4588","BK1100","02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180840598","title":"鹰瞳科技-B：4月30日回购2.63万股，耗资约31.43万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1180840598","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180840598?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:21","pubTimestamp":1777551717,"startTime":"0","endTime":"0","summary":"鹰瞳科技-B于2026年4月30日公告，披露公司当日在香港联交所场内回购2.63万股H股，约占该日前一交易日已发行股本0.026%。本次回购价格介乎每股11.70港元至12港元，总耗资约31.43万港元。回购完成后，截至2026年4月30日，公司已发行股本降至102,265,413股，库藏股增至1,302,600股，回购股份暂未注销并将予以库存持有。公告显示，股东大会已于2025年6月27日通过购回授权，授权最高回购股份总数为10,315,601股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"鹰瞳科技-B：4月30日回购2.63万股，耗资约31.43万港元","news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631634068","title":"鹰瞳科技-B(02251)4月30日斥资31.4万港元回购2.63万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2631634068","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631634068?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:15","pubTimestamp":1777551340,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，于2026年4月30日斥资31.4万港元回购2.63万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631667519","title":"鹰瞳科技-B(02251)4月29日斥资15.4万港元回购1.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2631667519","media":"中金财经","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631667519?lang=zh_cn&edition=full","pubTime":"2026-04-29 20:07","pubTimestamp":1777464421,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，于2026年4月29日斥资15.4万港元回购1.3万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260429/32189886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137516359","title":"鹰瞳科技-B（02251）2025年收入稳步增长 亏损大幅收窄 AI医疗应用多点开花","url":"https://stock-news.laohu8.com/highlight/detail?id=1137516359","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137516359?lang=zh_cn&edition=full","pubTime":"2026-04-29 20:05","pubTimestamp":1777464325,"startTime":"0","endTime":"0","summary":"2025年度，鹰瞳科技-B实现收入约人民币1.73亿元，同比增长10.8%；年度亏损由上年的约人民币2.65亿元收窄至约人民币24.36百万元，降幅达90.8%。毛利同比增长47.6%至约人民币1.28亿元，毛利率由2024年的55.4%提升至73.8%。同期净资产约人民币12.22亿元，较2024年末的约人民币12.77亿元略有下降，非控股权益出现由正转负的变化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"鹰瞳科技-B（02251）2025年收入稳步增长 亏损大幅收窄 AI医疗应用多点开花","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108341776","title":"鹰瞳科技-B回购1.3万股股份，总额约15.42万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108341776","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108341776?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:50","pubTimestamp":1777463450,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司于2026年4月29日发布公告，披露公司当日在香港联交所场内回购股份事宜。根据公告，公司于2026年4月29日回购13,000股H股，占回购前已发行股本约0.013%。本次回购价格介于每股11.70港元至12.00港元之间，涉资约15.42万港元。公告显示，公司现可根据2025年6月27日通过的购回授权，回购股份总数为10,315,601股，截至目前已累计回购864,300股。公司确认，本次回购已遵守香港联交所证券上市规则及相关法例的规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"鹰瞳科技-B回购1.3万股股份，总额约15.42万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142925790","title":"鹰瞳科技-B回购2700股股份，总金额约3.25万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1142925790","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142925790?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:56","pubTimestamp":1777377361,"startTime":"0","endTime":"0","summary":"2026年4月28日，北京鹰瞳科技发展股份有限公司宣布于香港联交所场内回购普通股H股合计2700股，占回购前已发行股本约0.003%。本次回购价格区间为每股港币11.97元至12.10元，合计耗资港币3.25万，变动后公司已发行股份总数为103,568,013股，其中102,304,713股为流通股，库存股1,263,300股。根据公告，股东大会已于2025年6月27日通过相关购回授权，总可回购数量为10,315,601股，截至本次回购，公司已合计回购851,300股。公告由董事张大磊签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"鹰瞳科技-B回购2700股股份，总金额约3.25万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630309410","title":"鹰瞳科技-B(02251)4月28日斥资3.25万港元回购2700股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630309410","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630309410?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:56","pubTimestamp":1777377360,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，于2026年4月28日，该公司斥资3.25万港元回购2700股股份，每股回购价11.97-12.1港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435513.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630632233","title":"王世和定调一脉阳光(02522)战略升级：“场景+数据+AI”构建独有医学影像之路 定义未来、创造未来","url":"https://stock-news.laohu8.com/highlight/detail?id=2630632233","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630632233?lang=zh_cn&edition=full","pubTime":"2026-04-28 14:18","pubTimestamp":1777357119,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月28日，在一脉阳光战略升级暨全球数智影像生态大会上，集团创始人王世和在战略总结中明确提出：一脉阳光的独特优势在于“场景+数据+AI”的完整闭环，这也是别人“看得懂但学不来”的核心壁垒。王世和说，“一脉阳光的目标，是成为全球最大的数智影像生态领航者。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435128.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","BK1189","BK1219","CHAT","02251","02522","ARTY","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630932639","title":"一脉阳光(02522)×影禾医脉战略发布颅脑CT超级智能体：从“图像识别”到“图像理解”，医学影像AI迎来“检查项目级”杀手级应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2630932639","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630932639?lang=zh_cn&edition=full","pubTime":"2026-04-28 12:33","pubTimestamp":1777350793,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月28日，在一脉阳光战略升级暨全球数智影像生态大会上，一脉阳光正式发布，由孵化的人工智能企业影禾医脉和首都医科大学附属北京天坛医院共同研发的里程碑产品——颅脑CT超级智能体，这也是全球首个实现“检查项目级完整智能”的医学影像AI辅助诊断系统。此次发布标志着一脉阳光与影禾医脉的战略协同从技术孵化走向产品商业化落地，为医学影像AI从“单点工具”迈向“全病种、全流程智能”树立了新的行业标杆。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435106.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","BK1189","BK1219","CHAT","02251","02522","ARTY","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630733403","title":"一脉阳光(02522)拟合共约3.53亿港元进一步增持影禾医脉股权 合力打造医学影像AI核心壁垒","url":"https://stock-news.laohu8.com/highlight/detail?id=2630733403","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630733403?lang=zh_cn&edition=full","pubTime":"2026-04-27 07:31","pubTimestamp":1777246301,"startTime":"0","endTime":"0","summary":"截至本公告日期，目标公司2并无实际业务运营，目标公司2的唯一资产为持有的影禾医脉8.0000%股权。本次进一步增持影禾医脉股权，充分体现集团对影禾医脉未来长远发展的充足信心，并与一脉阳光数智影像+ 的整体转型升级发展需求形成高度战略契合。双方将依托各自核心优势深度协同、共生共荣，打造行业难以复制的医学影像AI核心壁垒。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","AIPO","BK1219","02522","BK1189","CHAT","ARTY","02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132182119","title":"鹰瞳科技-B：4月24日回购6500股股份，耗资约7.85万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132182119","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132182119?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:06","pubTimestamp":1777035999,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司（股票代码：02251，股票名称：鹰瞳科技-B）于2026年4月24日公告回购事宜。公司在香港联交所场内回购6500股H股，占回购前已发行股份总数（102,313,913股）的约0.006%，回购价介乎每股12.05港元至12.19港元，合计耗资约7.85万港元。\n回购完成后，公司已发行股份数变更为102,307,413股，库藏股增至1,260,600股。此次回购基于2025年6月27日通过的股份购回授权，公司可回购股份总数为10,315,601股，目前已累计购回848,600股。公司确认本次回购符合香港上市规则及相关法律规定，公告由公司董事张大磊签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"鹰瞳科技-B：4月24日回购6500股股份，耗资约7.85万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629445468","title":"鹰瞳科技-B(02251)4月24日斥资7.85万港元回购6500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629445468","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629445468?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:06","pubTimestamp":1777035961,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，于2026年4月24日斥资7.85万港元回购6500股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629049899","title":"德适：iMedImage医学影像基座模型覆盖超90%临床医学影像场景，可将专病AI模型研发成本降低90%以上","url":"https://stock-news.laohu8.com/highlight/detail?id=2629049899","media":"新浪科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629049899?lang=zh_cn&edition=full","pubTime":"2026-04-22 20:27","pubTimestamp":1776860820,"startTime":"0","endTime":"0","summary":"新浪科技讯 4月22日晚间消息，在2026第十届万物生长大会上，杭州德适生物科技股份有限公司携自研iMedImage医学影像基座模型，亮相“杭州AI十八罗汉”联展区。　　本次参展，德适重点展出两大核心产品：自主研发的iMedImage医学影像基座模型，以及基于该模型打造的AI AutoVision 染色体核型辅助诊断软件。据现场负责人介绍，iMedImage支持染色体、CT、MRI、超声及病理等19种医学影像模态，覆盖超90%的临床医学影像场景。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/2026-04-22/doc-inhvkqfy9348178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AGIX","CHAT","02251","AIPO","02526","BK1189","ARTY","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156218357","title":"鹰瞳科技-B于4月22日回购1200股股份，总额约1.45万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1156218357","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156218357?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:16","pubTimestamp":1776856594,"startTime":"0","endTime":"0","summary":"鹰瞳科技-B4月22日公告称，公司当日于香港联交所场内回购1200股，占回购前已发行股份约0.001%。本次回购的价格区间为每股12.00港元至12.19港元，合计支付约1.45万港元。本次回购基于公司于2025年6月27日通过的股份购回授权，该授权允许购回最多10,315,601股。截至目前，公司在各证券交易所合并购回股份数为842,100股，占授权通过时已发行股份总数的0.8163%。公司在公告中确认，本次回购已遵守香港联合交易所有限公司证券上市规则及相关法律规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"鹰瞳科技-B于4月22日回购1200股股份，总额约1.45万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629048488","title":"鹰瞳科技-B(02251)4月22日斥资1.45万港元回购1200股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629048488","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629048488?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:13","pubTimestamp":1776856428,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，于2026年4月22日斥资1.45万港元回购1200股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432077.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165729478","title":"鹰瞳科技-B：4月21日回购2,300股，耗资约2.78万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165729478","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165729478?lang=zh_cn&edition=full","pubTime":"2026-04-21 19:02","pubTimestamp":1776769373,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司于2026年4月21日发布公告，披露在香港联交所场内回购2,300股H股。该回购数量约占公告前公司已发行股份总数的0.002%，每股价格介乎港币12.05元至12.15元，总涉资约27,775港元。根据公告，本次回购完成后，公司已发行股份数目为102,315,113股，库藏股数量增加至1,252,900股，总股份数维持在103,568,013股。公司此前于2025年6月27日通过购回授权，可回购的股份总数为10,315,601股，截至目前已回购股份数为840,900股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"鹰瞳科技-B：4月21日回购2,300股，耗资约2.78万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629369033","title":"鹰瞳科技-B(02251)4月21日斥资2.78万港元回购2300股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629369033","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629369033?lang=zh_cn&edition=full","pubTime":"2026-04-21 19:01","pubTimestamp":1776769275,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，该公司于2026年4月21日斥资2.78万港元回购2300股股份，每股回购价格为12.05-12.15港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431408.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139701381","title":"鹰瞳科技-B：4月17日回购2900股，涉资约3.53万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139701381","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139701381?lang=zh_cn&edition=full","pubTime":"2026-04-17 20:16","pubTimestamp":1776428176,"startTime":"0","endTime":"0","summary":"鹰瞳科技-B（02251）于2026年4月17日公告，公司当日通过香港联交所场内回购2900股H股，约占回购前已发行股份的0.003%。回购价格介乎每股12.05港元至12.29港元，总耗资约3.53万港元。\n回购后，公司已发行股本（不含库藏股）为102,317,413股，库藏股数为1,250,600股，总计已发行股本为103,568,013股。该次回购依据2025年6月27日通过的购回授权进行，剩余可回购股份数量为10,315,601股。公司同时确认已遵守相关上市规则及法律规定。\n本公告由公司董事张大磊签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0523},{"period":"1month","weight":0.0458},{"period":"3month","weight":-0.0484},{"period":"6month","weight":-0.0594},{"period":"1year","weight":-0.0492},{"period":"ytd","weight":-0.0017}],"compareEarnings":[{"period":"1week","weight":0.0085},{"period":"1month","weight":0.0311},{"period":"3month","weight":-0.0353},{"period":"6month","weight":-0.0222},{"period":"1year","weight":0.1508},{"period":"ytd","weight":0.0105}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京鹰瞳科技发展股份有限公司是一家中国公司，主要专注于提供人工智能视网膜影像识别的早期检测诊断及健康风险评估解决方案。该公司的产品管线包括为医疗机构和大健康领域提供的眼底诊断人工智能SaMD、健康风险评估系统以及相应的智能硬件设备，打造了集软件和硬件于一体的解决方案。该公司还推出了针对儿童和青少年近视及斜弱视问题的人工智能治疗产品，实现了从检测、评估到治疗的一站式解决方案。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.071183},{"month":2,"riseRate":0.8,"avgChangeRate":0.116001},{"month":3,"riseRate":0.2,"avgChangeRate":-0.086289},{"month":4,"riseRate":0.2,"avgChangeRate":-0.01326},{"month":5,"riseRate":0.4,"avgChangeRate":-0.073265},{"month":6,"riseRate":0.5,"avgChangeRate":0.014792},{"month":7,"riseRate":0.25,"avgChangeRate":-0.034393},{"month":8,"riseRate":0.5,"avgChangeRate":-0.020416},{"month":9,"riseRate":0.25,"avgChangeRate":-0.059637},{"month":10,"riseRate":0.25,"avgChangeRate":-0.013194},{"month":11,"riseRate":0.75,"avgChangeRate":0.109538},{"month":12,"riseRate":0.4,"avgChangeRate":-0.09117}],"exchange":"SEHK","name":"鹰瞳科技-B","nameEN":"AIRDOC-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鹰瞳科技-B,02251,鹰瞳科技-B股票,鹰瞳科技-B股票老虎,鹰瞳科技-B股票老虎国际,鹰瞳科技-B行情,鹰瞳科技-B股票行情,鹰瞳科技-B股价,鹰瞳科技-B股市,鹰瞳科技-B股票价格,鹰瞳科技-B股票交易,鹰瞳科技-B股票购买,鹰瞳科技-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}